ResMed (BSP:R1MD34) Additional Paid-In Capital : R$9,202 Mil(As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is ResMed Additional Paid-In Capital?

ResMed's quarterly additional paid-in capital increased from Sep. 2023 (R$8,847 Mil) to Dec. 2023 (R$8,932 Mil) and increased from Dec. 2023 (R$8,932 Mil) to Mar. 2024 (R$9,202 Mil).

ResMed's annual additional paid-in capital increased from Jun. 2021 (R$8,157 Mil) to Jun. 2022 (R$8,492 Mil) and increased from Jun. 2022 (R$8,492 Mil) to Jun. 2023 (R$8,601 Mil).

ResMed Additional Paid-In Capital Historical Data

The historical data trend for ResMed's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Additional Paid-In Capital Chart

ResMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Additional Paid-In Capital

Get a 7-Day Free Trial

5,827.79

8,149.39

8,157.23

8,492.41

8,601.16

ResMed Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															9,005.65	8,601.16	8,846.95	8,931.93	9,202.36

ResMed Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

ResMed Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of ResMed's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed (BSP:R1MD34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (BSP:R1MD34) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMD:USA RMEA:Germany RME:Germany RMEA:Germany RME:Germany RMD:Australia

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

ResMed (BSP:R1MD34) Headlines

No Headlines